Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

XOMA Relative to the S&P 500

XOMA Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the XOMA Ltd. (NASD:XOMA) seasonal charts above shows that a Buy Date of August 19 and a Sell Date of January 7 has resulted in a geometric average return of 7.3% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 30.5% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a?role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

To download XOMA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: XOMA